申请人:GLAXOSMITHKLINE LLC
公开号:WO2011017395A1
公开(公告)日:2011-02-10
The present invention relates to highly functionalized 1,3-diamino-propan-2-ols and pharmaceutically acceptable salts thereof. More specifically, the invention relates to highly functionalized 1,3-diamino-propan-2-ols that are derivatives of the HIV protease inhibitors darunavir.
本发明涉及高度功能化的1,3-二氨基丙烷-2-醇及其药用盐。更具体地说,该发明涉及高度功能化的1,3-二氨基丙烷-2-醇,这些化合物是HIV蛋白酶抑制剂达芦那韦的衍生物。